Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
Introduction: Recurrent metastatic choriocarcinoma is a rare disease with historically limited guidance in the literature regarding standardized treatment protocols. In this case report, we review the course of a patient with recurrent metastatic choriocarcinoma re-treated with single agent pembroli...
Main Authors: | Adriana J. Wong, Lindsey Finch, Joseph Matt Pearson, Andre Pinto, Marilyn Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578922000352 |
Similar Items
-
Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
by: V. Paspalj, et al.
Published: (2021-08-01) -
A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab
by: Kaoru Niimi, et al.
Published: (2023-09-01) -
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
by: Sunil Kumar Das, et al.
Published: (2022-05-01) -
Metastatic Choriocarcinoma Following Live Birth A Rare Presentation
by: Joya Sree Roy, et al.
Published: (2011-09-01) -
CHORIOCARCINOMA (CASE REPORT)
by: L. I. Kokh
Published: (2016-02-01)